KYNB ▼ -4.6% - Kyntra Bio, Inc. $KYNB - Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation Kyntra Bio shares fell 4.6% today despite the company announcing a material reduction in its royalty financing obligation as part of an ongoing balance sheet transformation. The stock's decline suggests investors may have focused on other aspects of the restructuring or had concerns about the terms of the royalty reduction that outweighed the positive balance sheet news. 31-AUG-2026 04:06 PM ET